Immediate Impact
57 standout
Citing Papers
Cefepime–Taniborbactam in Complicated Urinary Tract Infection
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Mitsuaki Machida being referenced
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
2018 Standout
Clinical Response of Cefiderocol Compared with Imipenem/Cilastatin in the Treatment of Adults with Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis: Results from a Multicenter, Double-blind, Randomized Study (APEKS-cUTI)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mitsuaki Machida | 209 | 109 | 12 | 271 | 123 | 6 | 405 | |
| Tania Mashiach | 89 | 105 | 28 | 217 | 112 | 11 | 422 | |
| Chi-Chang Huang | 90 | 154 | 24 | 200 | 100 | 13 | 399 | |
| Nazim Mustafa | 132 | 68 | 18 | 310 | 57 | 11 | 442 | |
| Yuag-Meng Liu | 66 | 125 | 24 | 185 | 87 | 8 | 343 | |
| G. Muralidharan | 250 | 92 | 79 | 248 | 57 | 9 | 436 | |
| Joakim Isendahl | 130 | 82 | 22 | 128 | 73 | 7 | 427 | |
| Johanna Berkhout | 155 | 124 | 55 | 171 | 36 | 8 | 445 | |
| Mar Solé | 74 | 70 | 37 | 317 | 74 | 10 | 438 | |
| Maria C Losada | 269 | 101 | 20 | 254 | 134 | 13 | 416 | |
| Panagiota Lourida | 126 | 91 | 53 | 238 | 69 | 14 | 412 |
All Works
Loading papers...